SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-08-000874
Filing Date
2008-04-28
Accepted
2008-04-28 16:00:52
Documents
14
Period of Report
2008-06-13
Effectiveness Date
2008-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT regeneron_nps.htm DEF 14A 723774
2 GRAPHIC regeneron_nps1x10x1.jpg GRAPHIC 8791
3 GRAPHIC regeneron_nps1x10x2.jpg GRAPHIC 8506
4 GRAPHIC regeneron_nps1x10x3.jpg GRAPHIC 8423
5 GRAPHIC regeneron_nps1x1x1.jpg GRAPHIC 14799
6 GRAPHIC regeneron_nps1x1x2.jpg GRAPHIC 6123
7 GRAPHIC regeneron_nps1x3x1.jpg GRAPHIC 7121
8 GRAPHIC regeneron_nps1x8x1.jpg GRAPHIC 8669
9 GRAPHIC regeneron_nps1x8x2.jpg GRAPHIC 8404
10 GRAPHIC regeneron_nps1x8x3.jpg GRAPHIC 8898
11 GRAPHIC regeneron_nps1x9x1.jpg GRAPHIC 9066
12 GRAPHIC regeneron_nps1x9x2.jpg GRAPHIC 9143
13 GRAPHIC regeneron_nps1x9x3.jpg GRAPHIC 8714
14 GRAPHIC regeneron_nps1x9x4.jpg GRAPHIC 8538
  Complete submission text file 0001206774-08-000874.txt   885907
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19034 | Film No.: 08781186
SIC: 2834 Pharmaceutical Preparations